Select a community
MS
Find out more about the PatientsLikeMe
MS Community
Home > Community Treatment Reports > Uroxatral Treatment Report
What is Uroxatral?

Uroxatral is a brand name for the drug alfuzosin, an alpha-blocker used in men to treat benign prostatic hyperplasia (BPH).

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Bladder problems 9 1
Other 1 0

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
0 0%
Mild
0 0%
None
1 100%

Dosages

  daily 10 mg daily
  1 Number of Patients: 1 7 Number of Patients: 7  

Stop Reasons

Why Patients Stopped Taking Uroxatral (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work
3 100% Did not seem to work: 100%
Expense
2 67% Expense: 67%
Doctor's advice
2 67% Doctor's advice: 67%
Course of treatment ended
1 33% Course of treatment ended: 33%

See all 3 patients who’ve stopped taking Uroxatral

Currently Taking Uroxatral

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
1
1
2

Stopped Taking Uroxatral

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
2
1
0
0
0

Adherence, Burden & Cost See details from patient evaluations

Adherence

Taking treatment as prescribed

Always
1 100%
Usually
0 0%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
0 0%
Not at all
1 100%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
0 0%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 22, 2009.